Clevidipine in the Perioperative Treatment of Hypertension (ECLIPSE-NTG)

PHASE3CompletedINTERVENTIONAL
Enrollment

629

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

March 31, 2005

Study Completion Date

April 30, 2005

Conditions
Hypertension
Interventions
DRUG

clevidipine

DRUG

nitroglycerin

Trial Locations (28)

10016

New York University Medical Center, New York

21204

St Joseph Medical Center, Towson

22042

Inova Fairfax Hospital, Falls Church

23298

Virginia Commonwealth University Medical Center, Richmond

32504

Sacred Heart Health System, Pensacola

32901

Health First Holmes Regional Medical Center, Melbourne

34667

Regional Medical Center - Bayonet Point, Hudson

35209

Brookwood Medical Center, Birmingham

35213

Baptist Medical Center, Montclair, Birmingham

35235

Medical Center East, Birmingham

36116

Baptist Medical Center, South, Montgomery

45219

Sterling Research Group, Ltd., Cincinnati

The Christ Hospital, The Linder Clinical Trial Center, Cincinnati

48202

Henry Ford Health System, Detroit

60202

Saint Francis Hospital, Evanston

67214

Wesley Medical Center, Wichita

77024

Memorial Herman Memorial City Hospital, Houston

77030

The Methodist Hospital, Houston

77090

Houston Northwest Medical Center, Houston

85724

University Medical Center, Tucson

90033

Keck School of Medicine, University of Southern California, Los Angeles

91109

Huntington Memorial Hospital, Pasadena

92653

Saddleback Memorial Medical Center, Laguna Hills

96817

Kaiser Permanente Moanalua Medical Center, Honolulu

97239

Portland VA Medical Center, Portland

98405

Saint Joseph Medical Center, Tacoma

94143-0648

University of California, San Francisco

77030-4211

Michael E DeBakey VA Medical Center, Houston

Sponsors
All Listed Sponsors
lead

The Medicines Company

INDUSTRY